High Risk Percutaneous Coronary Interventions Online Course
Robert Applegate, MD, FSCAI
Professor of Cardiology Wake Forest University School of Medicine
This program is targeted to physicians and fellows-in-training and will offer didactic education on basic knowledge, potential complications, and treatment options for high risk PCI patients based on the latest information and best practices in this growing area of interventional cardiovascular medicine.
The High Risk PCI course is designed to enhance knowledge and understanding of high risk PCI through the following learning objectives:
- Comprehend the basic and advanced aspects of high risk percutaneous coronary interventions;
- Understand patient, device and therapy selection as it relates to high risk PCI;
- Compare outcomes in high risk PCI between individual centers and national statistics
Content Validation Statement
The Society for Cardiovascular Angiography and Interventions accepts the following Content Validation Statements and expects all persons involved in its professional education activities to abide by these statements with regard to any recommendations for clinical care.
All recommendations involving clinical medicine are based on evidence accepted within the profession of medicine as adequate justification for their indications and contradictions in the care of patients; AND/OR: All scientific research referred to or reported in support or justification of a patient care recommendation conforms to generally accepted standards of experimental design, data collection, and analysis.
|Robert Applegate, MD, FSCAI
||Speakers Bureau: Abbott, St. Jude; Advisory Board/Research Support: Abbott; Consultant: St. Jude
|Daniel Burkhoff, MD
|Navin Kapur, MD, FSCAI
||Nothing to Disclose
|John Lasala, MD, FSCAI
||Speaker's Bureau: Bristol Myers Squibb; Advisory Board: Eli Lilly
|Brijeshwar Maini, MD
||Nothing to Disclose
|Srihari Naidu, MD, FSCAI
||Advisory Board: Cordis, Abiomed; Consultant: Abbott, GE Healthcare
|Steven Yakubov, MD, FSCAI
||Speakers Bureau: Boehringer; Advisory Board: Boston Scientific, Abbott Vascular, Medtronic; Consultant/Shareholder: Gentre Heart
As a provider of continuing education through the Accreditation Council for Continuing Medical Education (ACCME), it is the Society's policy to ensure balance, independence, objectivity and scientific rigor in all of its programs. All participating faculty, course directors, and planning committee members are required to disclose to SCAI any financial relationships related to the subject matter of the program or committee in which they are participating. Disclosure information is reviewed in advance in order to manage and resolve any possible conflicts of interest. The intent of the disclosure is not to prevent the planner or presenter from being involved in the activity, but rather to provide participants with information on which they can make their own judgments.
This program is supported by educational grants from Abiomed.